Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Open accessThe DOI matches its Crossref record; 78 of the 93 references it cites were found in a registry or an index.
Abstract
The cell cycle inhibitor p16INK4a is inactivated in many human tumors and in families with hereditary melanoma and pancreatic cancer. Tumor-associated alterations in the INK4a locus may also affect the overlapping gene encoding p19ARF and the adjacent gene encoding p15I1NK4b, both negative regulators of cell proliferation. We report the phenotype of mice carrying a targeted deletion of the INK4a locus that eliminates both p16INK4a and p19ARF. The mice are viable but develop spontaneous tumors at an early age and are highly sensitive to carcinogenic treatments. INK4a-deficient primary fibroblasts proliferate rapidly and have a high colony-formation efficiency. In contrast with normal cells, the introduction of activated Ha-ras into INK4a-deficient fibroblasts can result in neoplastic transformation. These findings directly demonstrate that the INK4a locus functions to suppress neoplastic growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The early generation mTerc mice of the various Ink4a / Arf genotypes showed tumor incidence and median latencies similar to those reported previously for Ink4a / Arf wild-type and mutant mice (33) (Fig. 2 A ).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [33]
In the citing paper
“The G0 mTerc Ink4a / Arf -/ -MEFs were immortal as reported previously (33).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [33]
In the citing paper
“Similarly, about two- thirds of mice with knockout of Cdkn2a (the locus encoding p16 INK4a and the p53 upstream regulator p19 ARF ) develop fibrosarcomas, sarcomas or lymphomas at 5-9 months of age 129 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [129]
In the citing paper
“Primary murine fibroblasts lacking either p53 or p16 are transformed by oncogenic ras alone (Tanaka et al. 1994; Serrano et al. 1996) and are easily established into immortal cell lines (Harvey et al. 1993; Metz et al. 1995; Serrano et al. 1996).”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Serrano et al. 1996
Citations
Cites
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Self-citationMorgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Self-citationEffects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 2
- Kripke, 1994, Ultraviolet radiation and immunology, Cancer Res., 54, 6102
- Palmieri, 1989, Oncogene requirements for tumorigenicity, Curr. Topics Microbiol. Immunol., 148, 43
Cited by
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
“MEFs were prepared from day 13.5 embryos derived from crosses (150 mM NaCl, 1.0% NP-40, 50 mM Tris–HCl [pH 8.0], 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 1 mM sodium vanadate,between either p531/2 mice (Jacks et al., 1994) or p161/2 mice (Ser- rano et al., 1996).”
BackgroundMethodResultInfluentialSelf-citationDistinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
“Second, in constructs driven by heterologous promoters,et al., 1992; Jacks et al., 1994), p16INK4a (Serrano et al., 1996), the normal physiological regulation of gene expression gov-DPC4 (Sirard et al., 1998), and BRCA2 (Suzuki et al., 1997), has erned by the endogenous promoter is lost.”
Background
Metadata
- Authors
- Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A.
- Affiliations
- Howard Hughes Medical Institute (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Beach, David
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1996-04
- Volume
- 85
- Issue
- 1
- Pages
- 27-37
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2049085719
- Cited by
- 1,585
- References
- 93
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 16 · 2023: 29 · 2022: 27 · 2021: 30 · 2020: 37 · 2019: 26 · 2018: 21 · 2017: 41 · 2016: 35 · 2015: 50 · 2014: 44 · 2013: 57 · 2012: 39
- FWCI
- 39.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6316 d)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- National Institutes of Health (5r01hd028317-05, 5r01ey009300-10, 5t32ca009173-35)
- National Eye Institute (EY-09300)
- National Cancer Institute (CA‐09173)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 28317)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- p16INK4a, p19ARF, CDKN2B, tumor suppression, cell cycle inhibitors, cell proliferation, oncogenic transformation, spontaneous tumors, carcinogen sensitivity, melanoma, pancreatic cancer, fibroblasts, targeted gene deletion
- MeSH terms
- Alleles, Animals, Carrier Proteins, Cell Division, Cell Transformation, Neoplastic, Enzyme Inhibitors, Fibroblasts, Humans, Mice, Inbred C57BL, Phenotype, Proteins, Genes, Tumor Suppressor, Cell Death, Germ-Line Mutation, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of the INK4a Locus in Tumor Suppression and Cell Mortality. https://app.cochat.ai/papers/10.1016/s0092-8674(00)81079-x
- The paper
- Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996). Role of the INK4a Locus in Tumor Suppression and Cell Mortality. Cell. https://doi.org/10.1016/s0092-8674(00)81079-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.